![Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: value when multidrug regimens have failed to achieve blood pressure control | Journal of Human Hypertension Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: value when multidrug regimens have failed to achieve blood pressure control | Journal of Human Hypertension](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fjhh.2010.40/MediaObjects/41371_2010_Article_BFjhh201040_Figa_HTML.gif)
Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: value when multidrug regimens have failed to achieve blood pressure control | Journal of Human Hypertension
![Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9d3f971a-60ac-417d-9c55-2e0130c89e71/gr1.jpg)
Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology
![PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”](https://i1.rgstatic.net/publication/335764203_Reply_to_Very-low-dose_oral_minoxidil_in_male_androgenetic_alopecia_A_study_with_quantitative_trichoscopic_documentation/links/5e6e6acb92851c6ba706407c/largepreview.png)
PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”
![Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00448-x/MediaObjects/13555_2020_448_Fig1_HTML.jpg)